Artificial Intelligence
8.5% CAGR of Sepsis Diagnostics Market to Accumulate Value of USD 1,373.1 Million by 2032-End: Market.us
New York, July 18, 2023 (GLOBE NEWSWIRE) — As per the latest finding of Market.us, The Global Sepsis Diagnostics Market Revenue is expected to be USD 619.8 Million by the end of 2023. In the long term, the market is estimated to reach at around USD 1,373.1 Million by 2032 and it is poised to register a CAGR of 8.5% from 2023 to 2032.
Sepsis is a life-threatening condition caused by the body’s response to an infection. It occurs when chemicals released into the bloodstream to fight an infection trigger an inflammatory response throughout the body, which can lead to organ failure and death. Early diagnosis and treatment with antibiotics are essential for survival.
Key Takeaway
- By Technology, the microbiology segment has generated the highest revenue share during the forecast period (2023-2032).
- By Product, the blood culture media segment has dominated the market, and it is growing at the fastest CAGR over the forecast period.
- By Method, the automated diagnostics segment is significantly growing during the forecast period
- By test, the laboratory test segment dominates the market due to its precise results.
- By Pathogen, the bacterial sepsis segment dominates the market during the forecast period.
- By End User, the hospital segment anticipated growth during the forecast period.
- In 2022, North America dominated the market with the highest revenue share of 47%.
- Europe held a 37% revenue share in 2022.
- Asia-Pacific will grow the fastest CAGR during the forecast period
Don’t Miss Out: Get Your Hands On Our FREE PDF Sample Report to Uncover the Sepsis Diagnostics Market@ https://market.us/report/sepsis-diagnostics-market/request-sample
Sepsis diagnostics involve a range of laboratory tests, such as blood tests, urine tests, imaging scans, and other diagnostic procedures. These tests help determine the presence and severity of the infection and the extent of organ damage.
Factors Affecting the Growth of the Global Sepsis Diagnostics Market
There are several factors that can affect the growth of the global sepsis diagnostics market. Some of these factors include:
- Increasing Prevalence of Sepsis: Sepsis is a rapidly progressing and life-threatening condition caused by infection. According to the Centers for Disease Control and Prevention (CDC), approximately 1.7 million people are affected by sepsis in the U.S. each year, and more than 270,000 people die from sepsis annually. This increasing prevalence of sepsis is expected to drive the growth of the global sepsis diagnostics market during the forecast period.
- Technological Advancements in Diagnostic Tests: Technological advancements in the development of diagnostic tests for sepsis are expected to drive the growth of the global sepsis diagnostics market over the forecast period. For example, in October 2018, Abbott Laboratories developed a new diagnostic test that can detect sepsis and other bloodstream infections in as little as five hours.
- Increasing Government Initiatives: Increasing government initiatives to create awareness about sepsis and its causes are expected to propel the growth of the global sepsis diagnostics market over the forecast period. For example, in 2017, the U.K. government launched a national sepsis awareness campaign to spread awareness about the disease, its causes, and its symptoms.
- Increasing Investments in Research and Development: Increasing investments in research and development for the development of novel diagnostic tests for sepsis is expected to propel the growth of the global sepsis diagnostics market over the forecast period. For example, in 2019, Abbott Laboratories invested USD 300 million in its research and development activities to develop and commercialize novel diagnostics tests.
Download Your Guide: Explore the Rapid Growth Potential of the Sepsis Diagnostics Market – Get Our PDF Sample Report
Top Trends in Global Sepsis Diagnostics Market
The trend in sepsis diagnostics is towards automated diagnosis, which uses data-driven algorithms and artificial intelligence (AI) to identify sepsis more accurately and rapidly. This approach is expected to reduce the time required for treatment, improve patient outcomes, and reduce healthcare costs. Point-of-care diagnostics are becoming increasingly popular due to the ease and accuracy they offer. These diagnostics involve quick and simple tests that can be carried out at the patient’s bedside, providing rapid results without the need for expensive laboratory equipment. The use of molecular diagnostics is becoming increasingly common in sepsis diagnostics.
This involves using genetic and biochemical techniques to identify the presence of sepsis-causing bacteria and viruses in a patient’s blood. The use of genomic sequencing is becoming increasingly popular in sepsis diagnostics. This involves sequencing the entire genome of a patient to identify any mutations that may be associated with sepsis. This approach is expected to improve the accuracy of sepsis diagnosis and enable more personalized treatments.
Market Growth
The growth of the global sepsis diagnostics market is highly dependent on the advancement in Technology and the increasing incidence of nosocomial infections. Technological progress in the field of diagnostics has enabled the development of efficient and accurate sepsis diagnostics. Such as the development of next-generation sequencing (NGS) has enabled the identification of biomarkers associated with sepsis, which helps differentiate between infections caused by bacteria, viruses, and fungi.
Regional Analysis
North America is expected to be the biggest market for sepsis diagnostics due to its high prevalence of the condition and access to advanced treatments. Europe has the highest sepsis prevalence and mortality rate, making it the largest sepsis detection device market. The Asia Pacific is predicted to have the fastest growth due to increased research spending, an aging population, and poor hygiene in some areas. The World Health Organisation’s 2020 report showed that sepsis affects mostly people in poorer countries, and antibiotic resistance makes it harder to treat.
Buy the report today and receive exclusive access to industry trends and forecasts @ https://market.us/purchase-report/?report_id=103467
Scope of the Report
| Report Attributes | Details |
| Market Value (2022) | USD 628.7 Million |
| Market Size in 2032 | USD 1392.8 million |
| CAGR (2023 to 2032) | 8.5% |
| North America Revenue Share | 47.0% |
| Europe Revenue Share | 37.0% |
| Historic Period | 2016 to 2022 |
| Base Year | 2022 |
| Forecast Year | 2023 to 2032 |
Market Drivers
The growing focus on the early diagnosis of sepsis is driving the market growth. Early diagnosis is essential for better outcomes in sepsis treatment as it allows for fast and effective results. Such as the increasing awareness about sepsis and its diagnosis is expected to contribute to market growth. The rising prevalence of nosocomial infections and the growing demand for efficient diagnostic solutions are also likely to drive market growth.
Market Restraints
The global sepsis diagnostics market’s expansion is expected to restrain significantly due to the lack of skilled personnel and awareness about sepsis diagnosis among healthcare professionals. Sepsis is a life-threatening infection complication requiring prompt diagnosis and treatment.
Market Opportunities
The increasing incidence of sepsis, especially in developing countries, is expected to create lucrative opportunities for the market players. The growing demand for sepsis diagnostics devices, in general, is creating an opportunity for companies in the global sepsis diagnostics market to develop innovative and cost-effective products. Companies are also focusing on providing better customer service and improving the quality of healthcare services.
To understand how our report can bring a difference to your business strategy, Inquire about a brochure at https://market.us/report/sepsis-diagnostics-market/#inquiry
Report Segmentation of the Global Sepsis Diagnostics Market
By Technology Insight
The global sepsis diagnostics market is segmented based on Technology such as microbiology, molecular diagnostics, flow cytometry, immunoassays, and other technologies. The microbiology segment leads the global sepsis diagnostics market. This type of testing includes direct methods, such as cultures, microscopy, antigen detection, and specific gene detection, as well as indirect methods, like serology, which tests the levels of certain antibodies.
The two main functions of this testing are clinical means used to diagnose infections) and epidemiological (used to control and prevent infections). The molecular diagnostics segment is expected to grow the fastest as it is becoming more widely used for its accuracy and faster results. Research is being done to develop a molecular diagnostic that can detect both COVID-19 and sepsis and tell them apart from each other.
By Product Insight
Blood Culture Media refers to the type of media used to grow and detect microorganisms from a blood sample. It is a complex mixture of nutrients, growth promoters and inhibitors, pH buffers, and other components used to provide an optimal environment for the growth of bacteria and fungi. Blood culture media also contains a variety of indicators that allow for the detection of microbial growth, such as color changes or fluorescence. Instruments are used to detect and measure different parameters associated with sepsis, such as temperature, blood pressure, heart rate, and respiration rate. These instruments are typically connected to monitors that can display the readings in a graphical format.
This enables healthcare professionals to quickly diagnose and treat sepsis. Assay kits and reagents are used to detect and quantify specific molecules or metabolites in a sample. These kits can be used to diagnose sepsis by detecting and measuring certain biomarkers that are associated with the condition. Software is used to track and analyze patient data, as well as to generate reports that can be used to identify trends and make decisions. The software can also be used to automate certain processes, such as ordering tests or medications, which can help to improve efficiency.
By Method Insight
The global sepsis diagnostics market by method is segmented into automated diagnostics and conventional diagnostics. The conventional technique was the most profitable due to this characteristic of conventional diagnostics dominating the market during the forecast period. It was used a lot by hospitals, independent clinical labs, and pathology labs, which is why it made the most money. Automated Diagnostics is gaining popularity as it gives results faster and is more sensitive than the conventional technique.
By Test Insight
The global sepsis diagnostics market by test is segmented into laboratories test and point of care (POC) tests. Laboratory testing has been the leader in the testing market due to its more precise results when compared to Point of Care (POC) testing. Additionally, Clinical Laboratory testing is capable of offering a comprehensive evaluation of pathogens, drug resistance profiling, and testing of lactate levels.
By Pathogen Insight
Bacterial sepsis is the most common type of sepsis, with 62.2% of patients infected with gram-negative bacteria and 46.8% with gram-positive bacteria. This has caused bacterial sepsis to have the largest share of the market. Fungal sepsis is predicted to have the fastest growth rate due to an increase in Candida infection, which can lead to sepsis poisoning.
By End-User Insight
As per End-User analysis, Hospital Laboratories make up the largest revenue segment to the increasing prevalence of hospital-acquired infections (HAIs). The World Health Organization (WHO) reported that the incidence of ICU-acquired infections, such as surgical-site wound infections and UTIs, are two to three times higher in developing countries compared to developed countries. Laboratories are the fastest-growing segment due to their access to advanced diagnostic technologies that offer faster, more reliable, and more precise results. Additionally, they receive orders for blood culture tests outsourced by hospitals.
Connect with our analysts to discuss the market and gain strategic insights@ https://market.us/book-appointment/?report_id=103467
Market Segmentation
By Technology
- Microbiology
- Molecular Diagnostics
- Flow Cytometry
- Immunoassays
- Other Technologies
By Product
- Blood Culture Media
- Instruments
- Assay kits & Reagent
- Software
By Method
- Automated Diagnostics
- Conventional Diagnostics
By Test
- Laboratory Test
- Point of Care (POC) Test)
By Pathogen
- Bacterial Sepsis
- Viral Sepsis
- Fungal Sepsis
- Other Pathogens
By End-User
- Hospitals
- Pathology
- Laboratory
- Other End-Users
By Geography
North America
- The US
- Canada
- Mexico
Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Competitive Landscape
The competitive landscape of the market has also been examined in this report. Some of the major players include
- BioMérieux SA
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Hoffmann-La Roche AG
- Danaher Corporation (Beckman Coulter, Inc.)
- Wolters Kluwer NV.
- Bruker Corporation
- E. Healthcare
- Amara Health Analytics
- Cerner Corporation
- Mckesson Corporation
- Luminex Corporation
- Epic Systems Corporation
- Koninklijke Philips N.V.
- Other Key Players
Recent Development of the Global Sepsis Diagnostics Market
- In 2018, Abbott Laboratories launched the new I-STAT handheld blood testing platform in Europe. This platform is used for performing blood tests for the diagnosis of sepsis.
- In 2017, BioMérieux launched the VITEK MS microbial identification system in the U.S. This system is used for the diagnosis of sepsis.
- Becton, Dickinson, and Company launched the Sepsityper Test in 2018. This test is used to identify the pathogens causing sepsis.
- In 2017, Cepheid launched the Xpert Xpress MRSA/SA Test.
Take a Look at our Related Reports
- Immunoassay industry was valued at USD 27.8 billion in 2021. This market is expected to reach USD 46.56 billion in 2032 at a CAGR of 4.8%, between 2023-2032.
- Diagnostics Imaging Market accounted for USD 33.0 Bn and is expected to reach around USD 54.6 Bn in 2032, register a CAGR of 5.3%.
- Transplant Diagnostics Market size is expected to be worth around USD 7,332 Million by 2032 from USD 3,400 Million in 2022, growing at a CAGR of 8.20% during the forecast period
- Autoimmune Disease Diagnostics Market size is expected to be USD 10.3 Bn by 2032 at a CAGR of 7.1% forecast period from 2023 to 2032.
About Us:
Market.US (Powered by Prudour Pvt Ltd) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report-providing firm. Market.US provides customization to suit any specific or unique requirement and tailor-makes reports as per request. We go beyond boundaries to take analytics, analysis, study, and outlook to newer heights and broader horizons.
Follow Us On LinkedIn Facebook Twitter
Our Blog:
Artificial Intelligence
2024 Rank Prizes Awarded in London for Research into Type 2 Diabetes and Retinal Imaging
The Rank Prize for Nutrition has been awarded to Professor Roy Taylor and Professor Mike Lean
The Rank Prize for Optoelectronics has been awarded to four pioneers of retinal imaging technology
LONDON, July 2, 2024 /PRNewswire/ — The 2024 Rank Prizes were awarded last night at a ceremony in central London. Dame Sally Davies, the UK Special Envoy on Antimicrobial Resistance, was Guest of Honour.
Rank Prize for Nutrition
Professor Roy Taylor and Professor Mike Lean were the winners of the 2024 Rank Prize for Nutrition. Their research has furthered understanding of how type 2 diabetes develops, and has shown for the first time that remission from type 2 diabetes is possible for some by following a low-energy weight management programme. Their work is transforming services for people newly diagnosed with type 2 diabetes by giving them the support to manage their health and reverse the effects of this serious condition.
Professor John C. Mathers, Chair of Rank Prize’s Nutrition Committee, explained that: “The ground-breaking research by Professors Taylor and Lean has shown that a diagnosis of type 2 diabetes is not a life sentence. Their demonstration that type 2 diabetes can be put into remission by sustained weight loss will empower millions of people globally to change their eating behaviour and to improve their health.”
On receiving the award, Professor Lean commented that: “Success in research, making a difference for our patients, is gratifying, and for all this to be recognised by the Rank Prize is immensely rewarding.” Professor Taylor added: “I am delighted to receive this recognition on behalf of the physicists, doctors, nurses, dietitians and others who have provided fantastic team input over many years of this research.”
Rank Prize for Optoelectronics
The 2024 Rank Prize for Optoelectronics was awarded to four internationally leading scientists for the development of instruments that use adaptive optics technologies to capture high-resolution images of the living human retina. Their pioneering research has generated new fundamental insights into the structure and function of the human eye in both health and disease as well as new clinical interventions to remedy sight loss from common disorders. The winning scientists are:
Dr Junzhong LiangProfessor Donald T. MillerProfessor Austin RoordaProfessor David R. WilliamsProfessor Donal Bradley, Chair of Rank Prize’s Optoelectronics Committee, noted that: “The Prize recognizes a seminal contribution to imaging within the eye that opens new opportunities to understand this complex optical instrument and to improve eyesight through precise interventions. The winners are to be commended both on their highly insightful contributions to vision science and their subsequent development of applications.”
Professor David R. Williams responded: “Inventions and discoveries are almost always made by teams and this certainly was the case in this instance. I am so proud to be sharing this award with my former teammates, each of whom was not only critical to the initial development of ophthalmic adaptive optics but also continues to lead its evolution so successfully.”
About the Rank Prize
Established by Lord J. Arthur Rank, a British industrialist and philanthropist, the Rank Prizes are awarded biennially in the fields of nutrition and optoelectronics. Previous winners include Arthur Ashkin and Shuji Nakamaru, who have gone on to win the Nobel Prize. Find out more at www.rankprize.org.
Photo: https://mma.prnewswire.com/media/2452618/2024_Rank_Prize_Winners.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/2024-rank-prizes-awarded-in-london-for-research-into-type-2-diabetes-and-retinal-imaging-302188051.html
Artificial Intelligence
The top cyber security competition in the Eastern Hemisphere has been successfully concluded. Matrix Cup has achieved multiple “industry Top”.
QINGDAO, China, July 2, 2024 /PRNewswire/ — Recently, the Matrix Cup Cyber Security Competition came to an end at the Qingdao International Convention Center. The competition set up three major tracks: Vulnerability Mining Competition, Artificial Intelligence (Large Model) Challenge, and Team Offensive and Defensive Competition, attracting more than 1,000 teams and nearly 3000 players from many countries around the world to jointly launch an attack on the 20 million prize.
It is reported that as the largest cyber security competition in the Eastern Hemisphere, with the highest prize money and the top offensive and defensive competitions, the Matrix Cup has set a number of “top” in the industry. In terms of track settings, the Matrix Cup has set up three major tracks and five major events, achieving full coverage of mainstream event types in the industry for the first time. In terms of team size, the Matrix Cup has attracted more than 1,000 teams and nearly 3,000 players from scientific research institutions and government and enterprise units around the world to sign up for the competition. It is worth mentioning that the proportion of female players in the Matrix Cup far exceeds that of similar events, and they fully demonstrated the charm of female hackers in the competition, and also achieved remarkable results. In terms of competition results, the Matrix Cup has made many breakthroughs in internationally renowned software and hardware products. In terms of technological innovation, the competition included innovative products such as large models into the target for the first time, and set up an AI (large model) track to cultivate AI practical talents at the same time. In addition, the competition staged a 3v3 man-machine competition to create a benchmark event for technological innovation of “safety + AI”.
The Matrix Cup Cybersecurity Competition, based on the concept of “real network, real soldiers, real combat, and real training”, aims at enhancing the practical capabilities of security talents through simulation of confrontation, simulation of infiltration, and simulation of attack and defense, and to identify system vulnerabilities and threats. The competition team showed a world-class level in the competition, and the players challenged mainstream applications such as network core devices, office products, cloud services, mobile devices, operating systems, browsers, and databases, as well as artificial AI large model applications through clever techniques such as joint exploitation of multiple vulnerabilities, reflecting the value of international network security attacks and competition.
In the future, the Matrix Cup will continue to take the responsibility of selecting and cultivating cybersecurity talents with practical capabilities, effectively contribute to the development of new quality productive forces.
Photo – https://mma.prnewswire.com/media/2452816/image_5029886_41510308.jpg
View original content:https://www.prnewswire.co.uk/news-releases/the-top-cyber-security-competition-in-the-eastern-hemisphere-has-been-successfully-concluded-matrix-cup-has-achieved-multiple-industry-top-302188018.html
Artificial Intelligence
PolyU study reveals the mechanism of bio-inspired control of liquid flow, enlightening breakthroughs in fluid dynamics and nature-inspired materials technologies
HONG KONG, July 2, 2024 /PRNewswire/ — The more we discover about the natural world, the more we find that nature is the greatest engineer. Past research believed that liquids can only be transported in fixed direction on species with specific liquid communication properties and cannot switch the transport direction. Recently, The Hong Kong Polytechnic University (PolyU) researchers have shown that an African plant controls water movement in a previously unknown way – and this could inspire breakthroughs in a range of technologies in fluid dynamics and nature-inspired materials, including applications that require multistep and repeated reactions, such as microassays, medical diagnosis and solar desalination etc. The study has been recently published in the international academic journal Science.
Liquid transport is an unsung miracle of nature. Tall trees, for example, have to lift huge amounts of water every day from their roots to their highest leaves, which they accomplish in perfect silence. Some lizards and plants channel water through capillaries. In the desert, where making the most of scarce moisture is vital, some beetles can capture fog-borne water and direct it along their backs using a chemical gradient.
Scientists have long sought to hone humankind’s ability to move liquids directionally. Applications as diverse as microfluidics, water harvesting, and heat transfer depend on the efficient directional transport of water, or other fluids, at small or large scales. While the above species provide nature-based inspiration, they are limited to moving liquids in a single direction. A research team led by Prof. WANG Liqiu, Otto Poon Charitable Foundation Professor in Smart and Sustainable Energy, Chair Professor of Thermal-Fluid and Energy Engineering, Department of Mechanical Engineering of PolyU, has discovered that the succulent plant Crassula muscosa, native to Namibia and South Africa, can transport liquid in selected directions.
Together with colleagues from the University of Hong Kong and Shandong University, the PolyU researchers noticed that when two separate shoots of the plant were infused with the same liquids, the liquids were transported in opposite directions. In one case, the liquid travelled exclusively towards the tip, whereas the other shoot directed the flow straight to the plant root. Given the arid but foggy conditions in which C. muscosa lives, the ability to trap water and transport it in selected directions is a lifeline for the plant.
As the shoots were held horizontally, gravity can be ruled out as the cause of the selective direction of transport. Instead, the plant’s special properties stem from the tiny leaves packed onto its shoots. Also known as “fins”, they have a unique profile, with a swept-back body (resembling a shark’s fin) tapering to a narrow ending that points to the tip of the plant. The asymmetry of this shape is the secret to C. muscosa’s selective directional liquid transport. It all has to do with manipulating the meniscus – the curved surface on top of a liquid.
Specifically, the key lies in subtle differences between the fin shapes on different shoots. When the rows of fins bend sharply towards the tip, the liquid on the shoot also flows in that direction. However, on a shoot whose fins – although still pointing at the tip – have a more upward profile, the direction of movement is instead to the root. The flow direction depends on the angles between the shoot body and the two sides of the fin, as these control the forces exerted on droplets by the meniscus – blocking flow in one direction and sending it in the other.
Armed with this understanding of how the plant directs liquid flow, the team created an artificial mimic. Dubbed CMIAs, for ‘C. muscosa-inspired arrays’, these 3D-printed fins act like the tilted leaves of C. muscosa, controlling the orientation of liquid flow. Cleverly, while the fins on a natural plant shoot are immobile, the use of a magnetic material for artificial CMIAs allows them to be reoriented at will. Simply by applying a magnetic field, the liquid flow through a CMIA can be reversed. This opens up the possibility of liquid transport along dynamically changing paths in industrial and laboratory settings. Alternatively, flow could be redirected by changing the spacing between fins.
Numerous areas of technology stand to benefit from CMIAs. Prof. Wang said, “There are foresee applications of real-time directional control of fluid flow in microfluidics, chemical synthesis, and biomedical diagnostics. The biology-mimicking CMIA design could also be used not just for transporting liquids but for mixing them, for example in a T-shaped valve. The method is suited to a range of chemicals and overcomes the heating problem found in some other microfluidic technologies.”
View original content:https://www.prnewswire.co.uk/news-releases/polyu-study-reveals-the-mechanism-of-bio-inspired-control-of-liquid-flow-enlightening-breakthroughs-in-fluid-dynamics-and-nature-inspired-materials-technologies-302188001.html
-
Artificial Intelligence7 days agoAI Revolution Accelerates: North American Tech Companies Lead Amid Regulatory Changes
-
Artificial Intelligence4 days ago
CO2 AI Launches First Solution to Compute Product Emissions at Scale
-
Artificial Intelligence4 days ago
Spotlight on Authentic AI: Developers Making Real Contributions Beyond AI Washing Claims
-
Artificial Intelligence4 days agoAsia Pacific View: Foreigners Looking for the Most Practical Smart Technology at the 2024 World Intelligence Expo
-
Artificial Intelligence4 days agoLucinity’s AI Innovation Recognized at Microsoft’s Prestigious Global Partner Awards 2024
-
Artificial Intelligence4 days agoHybrid Memory Cube Market Size to Grow USD 18651.2 Million by 2030 at a CAGR of 18.6% | Valuates Reports
-
Artificial Intelligence4 days ago
Learning Pool Recognized with Two Industry Awards for Innovation and Product Excellence
-
Artificial Intelligence4 days ago
North American grocery retailer digitizes stores with Pricer Plaza in 90 MSEK order
